EMBJ Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Embraer is not a clear buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has supportive fundamentals and a few positive catalysts, but the current setup is not strong enough to justify an immediate buy at this price. My view is Hold, not Buy.
EMBJ is showing a mixed-to-neutral technical picture. The MACD histogram is positive and expanding, which supports short-term momentum, but the moving averages are bearish with SMA_200 > SMA_20 > SMA_5, showing the broader trend is still weak. RSI_6 near 70 suggests the stock is already extended in the near term rather than clearly undervalued. Price at 69 is also close to resistance at 69.53, while support sits lower at 67.57 and 64.39. Overall, momentum is improving, but the trend is not yet a clean long-term breakout setup.
Positive catalysts include the UAE contract for up to 20 C-390 military transport aircraft, which is a meaningful growth and backlog driver. Analysts at JPMorgan and BofA recently raised price targets and maintained bullish ratings, citing attractive valuation, stronger growth potential, and upside from Embraer's stake in Eve. Financial results from Q4 2025 also showed solid revenue growth, stronger net income, and higher EPS year over year.
The main near-term risk is the upcoming Q1 2026 earnings report before market open, which creates event risk. UBS recently cut its price target to $65 and kept a Neutral rating, showing not all analysts are bullish at current levels. Technically, the stock is still below a clean bullish trend structure, and historical pattern analysis suggests only modest near-term upside with a meaningful chance of a pullback. Gross margin also declined in the latest quarter, which tempers the earnings growth story.
In Q4 2025, Embraer showed healthy top-line and bottom-line growth. Revenue rose 12.84% YoY to about $2.66B, net income increased 83.36% YoY to about $82.8M, and EPS rose 83.33% YoY to 0.11. The main weak point was gross margin, which fell to 16.88, down 10.69% YoY. Overall, the latest quarter showed strong growth, but margin pressure remains a concern.
Analyst sentiment is mixed but leaning positive overall. JPMorgan raised its target to $84 and kept Overweight, and BofA raised its target to $80 with Buy ratings, both pointing to attractive valuation, growth potential, and upside from Eve. However, UBS cut its target to $65 and kept Neutral, which is a more cautious counterview. The Wall Street pros view is therefore constructive but not unanimous: bullish growth-case analysts see upside, while cautious analysts see fair value around current levels. For a beginner long-term investor, this is supportive but not enough to call it an immediate buy.
